DGAP-News

HAEMATO AG: Business performance in the first 9 months 2014

DGAP-News: HAEMATO AG / Key word(s): 9-month figures/Quarter Results
HAEMATO AG: Business performance in the first 9 months 2014

25.11.2014 / 12:07

---------------------------------------------------------------------

Corporate News of HAEMATO AG: Business performance in the first 9 months
2014

In the first 9 months 2014 HAEMATO AG, Berlin (ISIN: DE0006190705),
achieved IFRS Group sales of EUR 156.37 million (Prior-year period: EUR
118.30 million) and net profit for the period of EUR 6.60 million
(Prior-year period: EUR 6.15 million).

"By introducing botulinum preparations and hyaluronic acid we are now
developing our business in the strong growing lifestyle segment within the
healthcare market. We will continue to expand our range of products to
participate in the growth of this attractive market segment.

For the whole of 2014, we are still aiming for annual revenue of more than
EUR 200 million. Based on this assessment of the business development we
can reconfirm the established dividend policy for 2014", says Dr. Christian
Pahl, Member of the Management Board of HAEMATO AG.

About HAEMATO:

HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of the
business activities lies on the growth markets of patent free and patent
protected medicinal products. Focal points are therapies with cancer, HIV
and other chronic diseases.

The company is listed on the Frankfurt Stock Exchange in the Entry Standard
(Open Market).

Key figures for the share of HAEMATO AG:
Subscribed capital: EUR 20,778,898
Listed shares: ordinary shares
ISIN: DE000619070
WKN: 619070
Stock symbol: HAE
Dividend 2013: 0.30 Euro/share

Contact:
HAEMATO AG, Investor Relations
Telefon: [phone]
[e-mail]



---------------------------------------------------------------------

25.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


299225 25.11.2014